Paris
France
8
2023-10-05
7
2026-06-09
These are the the leading inventors for applications assigned to ENTEROME:
ENTEROME based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
USE OF ADLERCREUTZIA BACTERIA FOR THE TREATMENT OF INFLAMMATORY DISEASES
#2 | 2023-05-04PROCESS FOR PREPARING MANNOSE DERIVATIVES
#3 | 2021-10-07 ✅ Patent 11,560,399 granted on 2023-01-24Process for preparing mannose derivatives
#4 | 2020-09-03 ✅ Patent 11,898,210 granted on 2024-02-13Tools for assessing FimH blockers therapeutic efficiency
#5 | 2018-09-06 ✅ Patent 10,793,911 granted on 2020-10-06Host DNA as a biomarker of Crohn's disease
#6 | 2018-09-06 ✅ Patent 10,626,471 granted on 2020-04-21Gene signatures of inflammatory disorders that relate to the liver
#7 | 2018-08-23 ✅ Patent 10,543,223 granted on 2020-01-28Mannose derivatives useful for treating pathologies associated with adherent
#8 | 2016-09-08 ✅ Patent 9,873,914 granted on 2018-01-23Host DNA as a biomarker of Crohn's disease
Also check out ENTEROME's (Paris, France) applicant profile with 8 patent applications submitted.
139153 ⎘